Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 3Genitourinary 3Breast 3Head & Neck 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 11Thyroid Neoplasms 7Oropharyngeal Neoplasms 7Head and Neck Neoplasms 7Salivary Gland Neoplasms 5Mouth Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Breast Neoplasms 4Tongue Neoplasms 3Thyroid Cancer, Papillary 3Neuroendocrine Tumors 3Carcinoma 3Brain Neoplasms 3Adenocarcinoma, Follicular 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Nasopharyngeal Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Adrenal Gland Neoplasms 2

Interventions

pembrolizumab 7Cetuximab 5selpercatinib 3cemiplimab 3Trastuzumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Erlotinib Hydrochloride 3Bortezomib 3sargramostim 2motexafin gadolinium 2entinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Fluorodeoxyglucose F18 2Drug Therapy 2Docetaxel 2Biopsy 2ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1tipifarnib 1tanespimycin 1spartalizumab 1serabelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Fluorodeoxyglucose F18 × Head & Neck × Clear all
NCT01806675 2019-10-03

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Stanford University

Phase 1/2 Completed
25 enrolled 14 charts
BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Gliosarcoma, Breast Neoplasms, Male

NCT01254591 2013-08-26

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

National Cancer Institute (NCI)

Phase NA Unknown
500 enrolled
BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡